163 related articles for article (PubMed ID: 32109016)
1. Unwarranted imaging for distant metastases in patients with newly diagnosed ductal carcinoma in situ and stage I and II breast cancer.
Lupichuk S; Tilley D; Surgeoner B; King K; Joy AA
Can J Surg; 2020 Feb; 63(2):E100-E109. PubMed ID: 32109016
[TBL] [Abstract][Full Text] [Related]
2. Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry.
Henry NL; Braun TM; Breslin TM; Gorski DH; Silver SM; Griggs JJ
Cancer; 2017 Aug; 123(15):2975-2983. PubMed ID: 28301680
[TBL] [Abstract][Full Text] [Related]
3. Are Physicians Choosing Wisely When Imaging for Distant Metastases in Women With Operable Breast Cancer?
Simos D; Hutton B; Clemons M
J Oncol Pract; 2015 Jan; 11(1):62-8. PubMed ID: 25392522
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with imaging in patients with early breast cancer after initial treatment.
Enright K; Desai T; Sutradhar R; Gonzalez A; Powis M; Taback N; Booth CM; Trudeau ME; Krzyzanowska MK
Curr Oncol; 2018 Apr; 25(2):126-132. PubMed ID: 29719428
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma.
Hogan MP; Goldman DA; Dashevsky B; Riedl CC; Gönen M; Osborne JR; Jochelson M; Hudis C; Morrow M; Ulaner GA
J Nucl Med; 2015 Nov; 56(11):1674-80. PubMed ID: 26294295
[TBL] [Abstract][Full Text] [Related]
6. Baseline staging imaging for distant metastasis in women with stages I, II, and III breast cancer.
Arnaout A; Varela NP; Allarakhia M; Grimard L; Hey A; Lau J; Thain L; Eisen A
Curr Oncol; 2020 Apr; 27(2):e123-e145. PubMed ID: 32489262
[TBL] [Abstract][Full Text] [Related]
7. Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation.
Hahn EE; Tang T; Lee JS; Munoz-Plaza C; Adesina JO; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
J Oncol Pract; 2015 May; 11(3):e320-8. PubMed ID: 25901056
[TBL] [Abstract][Full Text] [Related]
8. Use and Yield of Baseline Imaging and Laboratory Testing in Stage II Breast Cancer.
Bychkovsky BL; Guo H; Sutton J; Spring L; Faig J; Dagogo-Jack I; Battelli C; Houlihan MJ; Yeh TC; Come SE; Lin NU
Oncologist; 2016 Dec; 21(12):1495-1501. PubMed ID: 27551013
[TBL] [Abstract][Full Text] [Related]
9. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
10. Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care?
Hahn EE; Tang T; Lee JS; Munoz-Plaza CE; Shen E; Rowley B; Maeda JL; Mosen DM; Ruckdeschel JC; Gould MK
Cancer; 2016 Mar; 122(6):908-16. PubMed ID: 26650715
[TBL] [Abstract][Full Text] [Related]
11. Breast Biopsy Intensity and Findings Following Breast Cancer Screening in Women With and Without a Personal History of Breast Cancer.
Buist DSM; Abraham L; Lee CI; Lee JM; Lehman C; O'Meara ES; Stout NK; Henderson LM; Hill D; Wernli KJ; Haas JS; Tosteson ANA; Kerlikowske K; Onega T;
JAMA Intern Med; 2018 Apr; 178(4):458-468. PubMed ID: 29435556
[TBL] [Abstract][Full Text] [Related]
12. Imaging for metastatic disease in patients with newly diagnosed breast cancer: are doctor's perceptions in keeping with the guidelines?
Simos D; Hutton B; Graham ID; Arnaout A; Caudrelier JM; Clemons M
J Eval Clin Pract; 2015 Feb; 21(1):67-73. PubMed ID: 25311965
[TBL] [Abstract][Full Text] [Related]
13. Comparison between positron emission tomography using 2-[fluorine-18]fluoro-2-deoxy-D-glucose, conventional imaging and computed tomography for staging of breast cancer.
Mahner S; Schirrmacher S; Brenner W; Jenicke L; Habermann CR; Avril N; Dose-Schwarz J
Ann Oncol; 2008 Jul; 19(7):1249-1254. PubMed ID: 18356138
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
Koolen BB; Vrancken Peeters MJ; Aukema TS; Vogel WV; Oldenburg HS; van der Hage JA; Hoefnagel CA; Stokkel MP; Loo CE; Rodenhuis S; Rutgers EJ; Valdés Olmos RA
Breast Cancer Res Treat; 2012 Jan; 131(1):117-26. PubMed ID: 21935602
[TBL] [Abstract][Full Text] [Related]
15. Baseline Estimates of Adherence to American Society of Clinical Oncology/American Board of Internal Medicine Choosing Wisely Initiative Among Patients With Cancer Enrolled With a Large Regional Commercial Health Insurer.
Ramsey SD; Fedorenko C; Chauhan R; McGee R; Lyman GH; Kreizenbeck K; Bansal A
J Oncol Pract; 2015 Jul; 11(4):338-43. PubMed ID: 26060225
[TBL] [Abstract][Full Text] [Related]
16. Imaging studies in patients with spinal pain: Practice audit evaluation of Choosing Wisely Canada recommendations.
Ferrari R
Can Fam Physician; 2016 Mar; 62(3):e129-37. PubMed ID: 27427564
[TBL] [Abstract][Full Text] [Related]
17. The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study.
Holm-Rasmussen EV; Jensen MB; Balslev E; Kroman N; Tvedskov TF
Eur J Cancer; 2017 Dec; 87():1-9. PubMed ID: 29096155
[TBL] [Abstract][Full Text] [Related]
18. Overuse of Preoperative Staging of Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
Srour MK; Lee M; Walcott-Sapp S; Luu M; Chung A; Giuliano AE; Amersi F
Ann Surg Oncol; 2019 Oct; 26(10):3289-3294. PubMed ID: 31342365
[TBL] [Abstract][Full Text] [Related]
19. Staging performance of whole-body DWI, PET/CT and PET/MRI in invasive ductal carcinoma of the breast.
Catalano OA; Daye D; Signore A; Iannace C; Vangel M; Luongo A; Catalano M; Filomena M; Mansi L; Soricelli A; Salvatore M; Fuin N; Catana C; Mahmood U; Rosen BR
Int J Oncol; 2017 Jul; 51(1):281-288. PubMed ID: 28535000
[TBL] [Abstract][Full Text] [Related]
20. MRI of occult breast carcinoma in a high-risk population.
Morris EA; Liberman L; Ballon DJ; Robson M; Abramson AF; Heerdt A; Dershaw DD
AJR Am J Roentgenol; 2003 Sep; 181(3):619-26. PubMed ID: 12933450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]